The Risk of Malignancy in Korean Patients with Rheumatoid Arthritis

다국어 초록 (Multilingual Abstract)

Purpose: To investigate the overall cancer risk and risk for specific cancers in rheumatoid arthritis (RA) patients in Korea by comparingcancer incidence between RA patients and the general population.
Materials and Methods: Individuals diagnosed with RA between 1996 and 2009 who underwent treatment at the Daegu CatholicUniversity Medical Center were retrospectively examined. 1885 patients with RA were included in the analyses. Occurrence ofcancer and death during follow up was ascertained by linking medical records to the Korean Central Cancer Registry and nationaldeath certificates. For comparing cancer incidence between RA patients and general population, standardized incidence ratios(SIR) were calculated. The 95% confidence intervals (CIs) of SIRs were calculated using the shortcut method introduced by Vandenbroucke.
Results: The total follow-up time was 10218.9 person-years. During follow up, 100 patients (31 men and 69 women) were diagnosedwith cancer. Both men and women had greater risks of having malignancy, although cancer risk was greater in men. Menshowed increased risks of lung cancer (SIR=5.46, 95% CI: 2.60–9.36) and leukemia (SIR=16.7, 95% CI: 1.58–47.9). Women showedincreased risks of thyroid cancer (SIR=1.75, 95% CI: 1.02–2.68), cervical cancer (SIR=3.65, 95% CI: 1.65–6.42), non-Hodgkin’s lymphoma(SIR=6.47, 95% CI: 2.04–13.4), and gallbladder cancer (SIR=3.87, 95% CI: 1.01–8.60). Disease-modifying anti-rheumaticdrugs usage and cancer were not related: the relative risks of developing malignancy were not elevated for each medicine.
Conclusion: The overall cancer incidence was increased in Korean men and women with RA. Increased risk of specific malignancydiffered according to sex.

참고문헌 (Reference)

1 Tokuhira M, "Therapy-related myeloid neoplasm in methotrexate-associated lymphoproliferative disease in a rheumatoid arthritis patient" 54 : 137-141, 2014

2 Cho SK, "The risk of malignancy and its incidence in early rheumatoid arthritis patients treated with biologic DMARDs" 19 : 277-, 2017

3 Chen YJ, "The risk of cancer in patients with rheumatoid arthritis : a nationwide cohort study in Taiwan" 63 : 352-358, 2011

4 Lin YC, "The agerisk relationship of hematologic malignancies in patients with rheumatoid arthritis : a nationwide retrospective cohort study" 34 : 1195-1202, 2015

5 Kim SK, "Smoking in elderly Koreans : prevalence and factors associated with smoking cessation" 56 : 214-219, 2013

6 정승민, "Risk of malignancy in patients with rheumatoid arthritis after anti-tumor necrosis factor therapy: results from Korean National Health Insurance claims data" 대한내과학회 34 (34): 669-677, 2019

7 Kim SC, "Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases : a population-based cohort study" 74 : 1360-1367, 2015

8 Khurana R, "Risk of development of lung cancer is increased in patients with rheumatoid arthritis : a large case control study in US veterans" 35 : 1704-1708, 2008

9 Parikh-Patel A, "Risk of cancer among rheumatoid arthritis patients in California" 20 : 1001-1010, 2009

10 Baecklund E, "Rheumatoid arthritis and malignant lymphomas" 16 : 254-261, 2004

11 Huang WK, "No overall increased risk of cancer in patients with rheumatoid arthritis : a nationwide dynamic cohort study in Taiwan" 34 : 1379-1386, 2014

12 Hai-Rim Shin, "Nationwide Cancer Incidence in Korea, 1999~2001; First Result Using the National Cancer Incidence Database" 대한암학회 37 (37): 325-331, 2005

13 Kim YJ, "Mortality and incidence of malignancy in Korean patients with rheumatoid arthritis" 39 : 226-232, 2012

14 Smedby KE, "Malignant lymphomas in autoimmunity and inflammation : a review of risks, risk factors, and lymphoma characteristics" 15 : 2069-2077, 2006

15 Wilton KM, "Malignancy incidence, management, and prevention in patients with rheumatoid arthritis" 4 : 333-347, 2017

16 Ahn HS, "Korea’s thyroid-cancer"epidemic"--screening and overdiagnosis" 371 : 1765-1767, 2014

17 Simon TA, "Incidence of malignancy in adult patients with rheumatoid arthritis : a meta-analysis" 17 : 212-, 2015

18 Yamada T, "Incidence of malignancy in Japanese patients with rheumatoid arthritis" 31 : 1487-1492, 2011

19 Hashimoto A, "Incidence of malignancy and the risk of lymphoma in Japanese patients with rheumatoid arthritis compared to the general population" 42 : 564-571, 2015

20 Wadström H, "Do RA or TNF inhibitors increase the risk of cervical neoplasia or of recurrence of previous neoplasia? A nationwide study from Sweden" 75 : 1272-1278, 2016

21 Centers for Disease Control, "Current cigarette smoking among adults - United States" 61 : 889-894, 2012

22 Abásolo L, "Cancer in rheumatoid arthritis : occurrence, mortality, and associated factors in a South European population" 37 : 388-397, 2008

23 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015" 대한암학회 50 (50): 303-316, 2018

24 Baecklund E, "Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis" 54 : 692-701, 2006

25 Korea Central Cancer Registry, "Annual report of cancer statistics in Korea in 2014" Ministry of Health and Welfare 2016

26 Alexson E, "Acute leukemia after azathioprine treatment of connective tissue disease" 273 : 335-340, 1977

27 JP V, "A shortcut method for calculating the 95 percent confidence interval of the standardized mortality ratio" 115 : 303-304, 1982